BB Biotech AG (BION) — Cash Flow Reinvestment Rate

Latest as of March 2025: 0.00x

BB Biotech AG (BION) has a Cash Flow Reinvestment Rate of 0.00x as of March 2025, reinvesting CHF0.00 (capex CHF0.00 ) from operating cash flow of CHF289.15 Million. Check BION cash flow quality index to evaluate the quality of earnings relative to operating cash generation.

Reinvestment Rate

0.00x
(Capex + Investments) / Operating CF

Total Reinvested

CHF0.00
Capex + Investments

Operating Cash Flow

CHF289.15 Million
CHF

Capital Expenditures

CHF0.00
CHF

BB Biotech AG Cash Flow Reinvestment Rate (2004–2025)

Historical reinvestment intensity for BB Biotech AG across 15 annual periods. Explore long-term investment intensity of BB Biotech AG to see how much of total assets are deployed in long-term investments.

Annual Cash Flow Reinvestment Rate for BB Biotech AG (2004–2025)

Year-by-year capital reinvestment analysis for BB Biotech AG. For live market cap and broader valuation context, see how much is BB Biotech AG worth.

Year Reinvestment Rate Total Reinvested (CHF) Operating CF Capex YoY Change
2025 0.00x CHF0.00 CHF309.14 Million CHF0.00
2024 0.00x CHF0.00 CHF304.56 Million CHF0.00
2023 0.00x CHF0.00 CHF218.28 Million CHF0.00
2020 0.00x CHF0.00 CHF262.45 Million CHF0.00
2019 0.00x CHF0.00 CHF215.02 Million CHF0.00
2017 0.00x CHF0.00 CHF687.50 Million CHF0.00
2015 0.00x CHF0.00 CHF652.82 Million CHF0.00
2014 0.00x CHF0.00 CHF1.47 Billion CHF0.00
2013 0.00x CHF0.00 CHF931.83 Million CHF0.00
2012 0.00x CHF0.00 CHF367.83 Million CHF0.00
2011 0.00x CHF0.00 CHF169.52 Million CHF0.00
2009 0.00x CHF0.00 CHF167.84 Million CHF0.00
2008 0.00x CHF0.00 CHF509.39 Million CHF0.00
2007 0.00x CHF0.00 CHF201.02 Million CHF0.00
2004 0.00x CHF0.00 CHF107.32 Million CHF0.00
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow